Rafaela is a partner at Mundi Ventures. She brings operational and investment experience from roles including CFO at QuintoAndar and investment banking senior associate at Goldman Sachs.
FA
Faisal Al-Hussein
Principal
Faisal brings investment banking and venture capital experience, having previously worked at Jefferies, Mundi Ventures, and BECO Capital.
The Series B round was co-led by Mundi Ventures and Opera Tech Ventures to support international growth and product scaling.
"We have been at the forefront of shaping digital automotive insurance solutions. Our approach to innovation, with a focus on exceptional user experience, has attracted and retained globally recognisable partners, demonstrating the value in our propositions."
The London-based reinsurance technology platform secured the Series A round led by Alven.
"This investment is reflective of the incredible support Supercede has received from a global community of buyers, brokers, and underwriters determined to bring better data and technology to the reinsurance industry. We are responding to their call to action, and with these funds will scale our capabilities to ensure our platform remains the top choice for reinsurance buying teams."
The round was co-led by IQ Capital and Mundi Ventures to support team expansion and product development.
"Synthesized substantially reduces the time to develop and comprehensively test data-driven projects and as a result empowers engineers to build better products and services for end users. With the new funding from IQ Capital and Mundi Ventures, Synthesized is well-positioned to facilitate its business operations to turbocharge development processes across many sectors, such as finance, insurance and healthcare. We will continue to double down on bringing the highest quality data infrastructure to our clients and partners."
The financing round was led by Kibo Ventures to fund the global rollout of the firm's home sleep testing technology.
"The response to AcuPebble SA100 since its launch has been incredible, and we are thrilled to see the product being used to help patients and clinicians in the real world. This funding will help us reach our initial goal of diagnosing one million patients and gives us the opportunity to continue working on new products that will fundamentally improve the lives of millions of people living with severe chronic conditions."
Notion Capital led the Series B round for Hokodo, with participation from continental European and existing investors.
"We’ve been following Hokodo since the beginning and made an initial investment as part of their Series A. We’re delighted to lead their Series B and double down on our support of Hokodo,"